BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71
18 results:

  • 1. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
    Liu T; Liu D; Jin Y; Dong M
    Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Association of Trefoil Factors with gastric cancer and Premalignant Lesions: A Cross-Sectional Population-Based Cohort Study.
    Zan X; Chen Z; Guo Q; Wang Y; Zhang Z; Ji R; Zheng Y; Zhang J; Wu Z; Li M; Wang X; Ye Y; Li X; An F; Xu C; Lu L; Fan P; Zhang J; Guan Q; Li Q; Liu M; Ren Q; Hu X; Lu H; Wang Y; Zhang H; Zhao Y; Gou X; Shu X; Wang J; Hu Z; Liu R; Yuan H; Liu J; Qiao L; Zhou Y
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):625-632. PubMed ID: 35027436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Adrenal Nodules Detected at Staging CT in Patients with Resectable gastric cancers Have a Low Incidence of Malignancy.
    Kim HY; Chang W; Lee YJ; Park JH; Cho J; Na HY; Ahn H; Hwang SI; Lee HJ; Kim YH; Lee KH
    Radiology; 2022 Jan; 302(1):129-137. PubMed ID: 34665031
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of cancer Cells.
    Gruffaz M; Yuan H; Meng W; Liu H; Bae S; Kim JS; Lu C; Huang Y; Gao SJ
    mBio; 2019 May; 10(3):. PubMed ID: 31088931
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials.
    Zhao TT; Xu H; Xu HM; Wang ZN; Xu YY; Song YX; Yin SC; Liu XY; Miao ZF
    Gastric Cancer; 2018 May; 21(3):361-371. PubMed ID: 29455269
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of Initial Recurrence in gastric Adenocarcinoma in the Era of Preoperative Therapy.
    Ikoma N; Chen HC; Wang X; Blum M; Estrella JS; Fournier K; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2017 Sep; 24(9):2679-2687. PubMed ID: 28332034
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
    Luo X; Xu H; He M; Han Q; Wang H; Sun C; Li J; Jiang L; Zhou Y; Dan H; Feng X; Zeng X; Chen Q
    Sci Rep; 2016 Jul; 6():29943. PubMed ID: 27416981
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. In Silico Interaction and Docking Studies Indicate a New Mechanism for pml Dysfunction in gastric cancer and Suggest Imatinib as a Drug to Restore Function.
    Imani-Saber Z; Ghafouri-Fard S
    Asian Pac J Cancer Prev; 2015; 16(12):5005-6. PubMed ID: 26163631
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
    Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
    Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
    Xu Z; Chen J; Shao L; Ma W; Xu D
    Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Promyelocytic Leukemia (pml) Gene Mutations may not Contribute to gastric Adenocarcinoma Development.
    Imani-Saber Z; Yousefi-Razin E; Javaheri M; Mirfakhraie R; Motalleb G; Ghafouri-Fard S
    Asian Pac J Cancer Prev; 2015; 16(8):3523-5. PubMed ID: 25921172
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Screening for gastric premalignant lesions with narrow band imaging, white light and updated Sydney protocol or both?
    Xirouchakis E; Laoudi F; Tsartsali L; Spiliadi C; Georgopoulos SD
    Dig Dis Sci; 2013 Apr; 58(4):1084-90. PubMed ID: 23086114
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
    Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
    PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence.
    Lee I; Park C; Kang WK
    Mol Cancer Ther; 2010 Nov; 9(11):2951-9. PubMed ID: 20841375
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Loss of promyelocytic leukemia protein in human gastric cancers.
    Lee HE; Jee CD; Kim MA; Lee HS; Lee YM; Lee BL; Kim WH
    Cancer Lett; 2007 Mar; 247(1):103-9. PubMed ID: 16713073
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.